The tech company BlackBerry Limited known for its phones which were popular a couple of years ago is now viral in the blockchain news section for its new announcement. According to a release, the company has now come up with a blockchain solution for secure data sharing among healthcare providers with the main aim of improving patient outcomes.
BlackBerry will use its network operation center (NOC) in order to power a blockchain digital ledger that will help create a secure global system for storing and sharing patient medical data, according to a release. The blockchain will be provided by Onebio which is a peer-to-peer marketplace for biodata.
As a long-time developer of smartphones and tablets, BlackBerry recently unveiled their new product called BlackBerry Spark which is an Enterprise-of-Things (EoT) platform that aims to transform the global delivery of healthcare data.
According to the CEO of BlackBerry and the current chairman, John Chen:
“At BlackBerry, we are applying our expertise in security, data privacy, and communication work in regulated industries such as automotive, financial services, and government to tackle one of the biggest challenges in the healthcare industry: leveraging healthcare endpoints to improve patient outcomes while ensuring security and data privacy.”
The new solution by the company may also improve medical data as we know it – but also enable it to remain tamper-proof and anonymous so that it can be shared with researchers. The company is also offering the ledger solution for the first time to the Global Commission which works to end the diagnostic chaos for children with rare diseases, the report added.
buy soft pack online blackmenheal.org/wp-content/themes/twentytwentytwo/inc/patterns/en/soft-pack.html no prescription
DC Forecasts is a leader in many crypto news categories, striving for the highest journalistic standards and abiding by a strict set of editorial policies. If you are interested to offer your expertise or contribute to our news website, feel free to contact us at [email protected]
Discussion about this post